Read + Share
Amedeo Smart
Independent Medical Education
Yang Q, He J, Yuan F. Improvement of proportion of days covered for denosumab under implementation of clinical pharmacist adherence management system: normal and COVID-19 period. Osteoporos Int 2024;35:309-316.PMID: 37801081
Email
LinkedIn
Facebook
Twitter
Privacy Policy